- Home
- SGBX vs PPBT Comparison
SGBX vs PPBT Comparison
Compare SGBX & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGBX
- PPBT
- Stock Information
- Founded
- SGBX 2007
- PPBT 2010
- Country
- SGBX United States
- PPBT Israel
- Employees
- SGBX N/A
- PPBT N/A
- Industry
- SGBX RETAIL: Building Materials
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- SGBX Consumer Discretionary
- PPBT Health Care
- Exchange
- SGBX Nasdaq
- PPBT Nasdaq
- Market Cap
- SGBX 2.2M
- PPBT 2.1M
- IPO Year
- SGBX 2017
- PPBT N/A
- Fundamental
- Price
- SGBX $8.83
- PPBT $0.57
- Analyst Decision
- SGBX
- PPBT Strong Buy
- Analyst Count
- SGBX 0
- PPBT 1
- Target Price
- SGBX N/A
- PPBT $33.00
- AVG Volume (30 Days)
- SGBX 151.3K
- PPBT 2.8M
- Earning Date
- SGBX 08-14-2025
- PPBT 08-06-2025
- Dividend Yield
- SGBX N/A
- PPBT N/A
- EPS Growth
- SGBX N/A
- PPBT N/A
- EPS
- SGBX N/A
- PPBT N/A
- Revenue
- SGBX $4,084,953.00
- PPBT N/A
- Revenue This Year
- SGBX $1,628.82
- PPBT N/A
- Revenue Next Year
- SGBX N/A
- PPBT N/A
- P/E Ratio
- SGBX N/A
- PPBT N/A
- Revenue Growth
- SGBX N/A
- PPBT N/A
- 52 Week Low
- SGBX $7.00
- PPBT $0.53
- 52 Week High
- SGBX $122.88
- PPBT $13.95
- Technical
- Relative Strength Index (RSI)
- SGBX 34.57
- PPBT 11.95
- Support Level
- SGBX $7.00
- PPBT $0.53
- Resistance Level
- SGBX $10.40
- PPBT $2.36
- Average True Range (ATR)
- SGBX 1.03
- PPBT 0.16
- MACD
- SGBX 0.70
- PPBT -0.13
- Stochastic Oscillator
- SGBX 28.29
- PPBT 2.05
About SGBX Safe & Green Holdings Corp.
Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.